On Dec. 2, the U.S. Food and Drug Administration (FDA) published a letter notifying health care providers about a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices.

The devices in limited supply include IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts. The FDA is working with Getinge to improve device availability, but the shortage is expected to continue into 2023.

Access FDA recommendations for providers and facilities here.

Clinical Topics: Cardiac Surgery, Heart Failure and Cardiomyopathies, Cardiac Surgery and Heart Failure, Mechanical Circulatory Support

Keywords: ACC Advocacy, United States Food and Drug Administration, Heart-Assist Devices, Catheters, Publications, Intra-Aortic Balloon Pumping

< Back to Listings